Bisphosphonate therapy for osteoporosis or other diseases with bone resorption may be associated with ocular inflammation.
Ocular inflammation has occurred with:
(1) alendronate sodium (Fosamax)
(2) etidronate disodium
(3) ibandronate (Boniva)
(4) pamidronate disodium
(5) risedronate (Actonel)
(6) sodium clodronate
Clinical signs and symptoms:
(1) abnormal or blurred vision
(2) vision loss
(3) ocular pain
(4) photophobia
Possible sites of inflammation - may be isolated or mixed:
(1) conjunctivitis
(2) scleritis
(3) episcleritis (inflammation of tissues overlying the sclera)
(4) uveitis
Finding |
Recommendation of Fraunfelder and Fraunfelder |
vision loss |
refer to ophthalmologist |
ocular pain |
refer to ophthalmologist |
isolated conjunctivitis |
may decrease with continued therapy |
scleritis or mixed inflammation |
discontinue bisphosphonate until inflammation resolves |
Specialty: Ophthalmology, Toxicology
ICD-10: ,